I was originally drawn to cc-TDI after discovering my cousin was diagnosed with stage 4 alveolar rhabdomyosarcoma. In the summer of 2015, I was lucky enough to intern at cc-TDI and study current resources for drug discovery for NF1-associated Pilocytic Astrocytoma (a brain tumor). I graduated from the University of Massachusetts Amherst in Spring 2017 with a chemical engineering degree. My research in the lab centers on the Building Blocks Project.
Charles Keller, MD
Scientific Director & Chief Mission Officer
